350
Participants
Start Date
July 31, 2003
Study Completion Date
December 31, 2005
moxifloxacin (with isoniazid, rifampin, pyrazinamide)
New York University School of Medicine, New York
Columbia University, New York
Harlem Hospital Center, New York
Washington DC Veterans Administration Medical Center, Washington D.C.
Johns Hopkins University, Baltimore
Emory University School of Medicine, Atlanta
Veterans Administration Tennessee Valley Health Care System, Nashville
Hines Vetrans Administration Medical Center, Hines
University of North Texas Health Science Center, Fort Worth
Houston Veterans Administration Medical Center, Houston
Audie L Murphy Memorial Veterans Administration Medical Center, San Antonio
Denver Public Health Department, Denver
University of Southern California Medical Center, Los Angeles
University of California at San Diego, San Diego
University of California, San Francisco, San Francisco
Seattle-King County Health Department, Seattle
Boston University Medical Center, Boston
New Jersey School of Medicine, Newark
University of British Columbia, Vancouver
University of Manitoba, Winnipeg
Montreal Chest Institute, Montreal
Nelson R Mandela School of Medicine, Durban
Makerere University Medical School, Kampala
Centers for Disease Control and Prevention
FED